Geranii Herba as a Potential Inhibitor of SARS-CoV-2 Main 3CL(pro), Spike RBD, and Regulation of Unfolded Protein Response: An In Silico Approach

Background: Since the first patient identified with SARS-CoV-2 symptoms in December 2019, the trend of a spreading coronavirus disease 2019 (COVID-19) infection has remained to date. As for now, there is an urgent need to develop novel drugs or vaccines for the SARS-CoV-2 virus. Methods: Polyphenoli...

Descripción completa

Detalles Bibliográficos
Autores principales: Arokiyaraj, Selvaraj, Stalin, Antony, Kannan, Balakrishnan Senthamarai, Shin, Hakdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761775/
https://www.ncbi.nlm.nih.gov/pubmed/33287311
http://dx.doi.org/10.3390/antibiotics9120863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761775/
https://www.ncbi.nlm.nih.gov/pubmed/33287311
http://dx.doi.org/10.3390/antibiotics9120863

Ejemplares similares